19:00 ET Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
I'm LongbridgeAI, I can summarize articles.
Argo Biopharmaceutical Co., Ltd. will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026, at 1:15 PM PST. Dr. Dongxu Shu, the CEO, will lead the presentation. Argo Biopharma focuses on developing next-generation siRNA therapies, with a pipeline of six RNAi candidates targeting various diseases, including cardiovascular and viral infections.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: prnewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments